Bioregenx annual gross margin
2021
2022
2023
2024
2025
Bioregenx Gross Margin Growth & History (BRGX)
Bioregenx's gross margin was 81.08% for fiscal 2025.
View full Bioregenx company overviewBioregenx annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 81.08% | +10.21 pp |
| 2024 | 2024-12-31 | 70.87% | +3.11 pp |
| 2023 | 2023-12-31 | 67.76% | −32.24 pp |
| 2022 | 2022-12-31 | 100.00% | +0.28 pp |
| 2021 | 2021-12-31 | 99.72% | — |
Bioregenx quarterly gross margin
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | 81.72% | +2.91 pp |
| Q4 2025 | 2025-12-31 | 82.66% | +12.58 pp |
| Q3 2025 | 2025-09-30 | 83.98% | +3.17 pp |
| Q2 2025 | 2025-06-30 | 79.03% | +15.02 pp |
| Q1 2025 | 2025-03-31 | 78.82% | +8.91 pp |
| Q4 2024 | 2024-12-31 | 70.09% | +14.33 pp |
| Q3 2024 | 2024-09-30 | 80.81% | +8.92 pp |
| Q2 2024 | 2024-06-30 | 64.01% | −5.29 pp |
| Q1 2024 | 2024-03-31 | 69.90% | −1.12 pp |
| Q4 2023 | 2023-12-31 | 55.76% | — |
| Q3 2023 | 2023-09-30 | 71.89% | — |
| Q2 2023 | 2023-06-30 | 69.31% | — |
| Q1 2023 | 2023-03-31 | 71.02% | — |
Bioregenx gross margin trends
Across the available reported history, Bioregenx's gross margin increased from 70.87% to 81.08%, a change of +10.21 percentage points. The latest reported quarter, Q1 2026, shows 81.72%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioregenx filings at SEC.gov ↗